Skip to main content
In this issue: Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.

Pharmacology Watch: Rivaroxaban: Another Warfarin Replacement

January 1, 2011

In this issue: Rivaroxaban may be dabigatran's first competitor; a new way to measure non-adherence to medication therapy; FDA Actions.